For those without a goal to lose weight, the program adapts to focus on overall health improvements that you can see for yourself in the biomarker testing every 4 months
Raz I, Fonseca V, Kipnes M, Durrwell L, Hoekstra J, Boldrin M, et al
have diabetes, which is often connected to obesity and raises the risk of cancer
As these patterns emerge, we can now identify two distinct consumer segments - the first is current users dealing with side effects, and the second is past users focused on weight maintenance. For current users, side effects represent a major concern, Sibley explained, noting that up to 50% report some kind of side effect, mostly gastrointestinal: nausea, vomiting, diarrhea, constipation, etc. GLP-1 drug user demographics The key GLP-1 drug users sit between the 25 and 44 age mark
Additionally, insulin resistance, chronic inflammation, and the psychological burden of managing chronic disease can all contribute to cognitive symptoms